Docusate Sodium
Product Images NDC 68210-0402

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Docusate Sodium (NDC 68210-0402). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Spirit Pharmaceuticals,llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Docusate Sodium 01)

This is a label for a shipment of Docusate Sodium capsules, each containing 50mg of the active ingredient, manufactured by Softgel Healthcare Pvt Ltd in India and distributed by Spirit Pharmaceuticals LLC in Fairless Hills, PA. The label includes storage instructions, warnings to keep out of reach from children, and instructions to approved repackaging before distribution. The bulk shipment is intended for further processing only. There is a caution statement indicating that this product is intended for manufacturing, processing, or repacking. There is also a list of numeric values in a hierarchy.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.